Technological Innovations and Research Frontiers in Interventional Therapy for Mitral Regurgitation
Reviews in Cardiovascular Medicine · 29.05.2026 · 27 (5)
DOI: 10.31083/rcm46175 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 29.05.2026. Verfasst von Shuang Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Ultrasound, Zhongnan Hospital of Wuhan University, Wuhan University, 430071 Wuhan, Hubei, China. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hubei Provincial Natural Science Foundation Joint Fund Project, Hubei Province Key research and development projects, Wuhan University Zhongnan Hospital Science and Technology Achievement Transformation Fund Clinical Research and Development Fund.
Abstract (Originalsprache)
Mitral regurgitation (MR) is a common valvular heart diseasewhose prevalence continues to increase with population aging, posing a serious threat to human health in the advanced stages of the disease. Sole reliance on medication and traditional surgical treatments can no longer meet the therapeutic needs of all patients. Transcatheter interventional therapy is gradually emerging as a promising new treatment option. Recently, technologies for the transcatheter interventional treatment of MR have advanced rapidly, with expanding indications and a continuous stream of new devices. The field has entered a phase of accelerated development in the treatment of structural heart disease, demonstrating broad clinical prospects. This article reviews the key technologies and developmental trends in the current transcatheter interventional treatments for MR, aiming to provide a theoretical basis and rationale for the safe and standardized implementation and broader adoption of these technologies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Ultrasound, Zhongnan Hospital of Wuhan University, Wuhan University, 430071 Wuhan, Hubei, China.
- Department of Cardiovascular Surgery, Zhongnan Hospital of Wuhan University, 430071 Wuhan, Hubei, China.
ORCID-Profile: Shuang Wang, Bin Wang
Förderung
- Hubei Provincial Natural Science Foundation Joint Fund Project
- Hubei Province Key research and development projects
- Wuhan University Zhongnan Hospital Science and Technology Achievement Transformation Fund Clinical Research and Development Fund
- Medical Science and Technology Innovation Platform Support Project of Zhongnan Hospital of Wuhan University
- Science and Technology Innovation Cultivation Fund of Zhongnan Hospital of Wuhan University
Zitieren
APA
Wang, S., Wang, A., Huang, Y., Liu, J., & Wang, B. (2026). Technological Innovations and Research Frontiers in Interventional Therapy for Mitral Regurgitation. Reviews in Cardiovascular Medicine, 27(5). https://doi.org/10.31083/rcm46175
Vancouver
Wang S, Wang A, Huang Y, Liu J, Wang B. Technological Innovations and Research Frontiers in Interventional Therapy for Mitral Regurgitation. Reviews in Cardiovascular Medicine. 2026;27(5). doi:10.31083/rcm46175
BibTeX
@article{Wang2026,
author = {Wang, Shuang and Wang, Aili and Huang, Yuna and Liu, Jinping and Wang, Bin},
title = {Technological Innovations and Research Frontiers in Interventional Therapy for Mitral Regurgitation},
journal = {Reviews in Cardiovascular Medicine},
year = {2026},
volume = {27},
number = {5},
doi = {10.31083/rcm46175}
}
EUVIMED